HeartSciences ROE 2022-2024 | HSCS
Current and historical return on equity (ROE) values for HeartSciences (HSCS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| HeartSciences ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-01-31 | $-0.01B | $0.01B | -466.67% |
| 2023-10-31 | $-0.01B | $-0.00B | 800.00% |
| 2023-07-31 | $-0.01B | $-0.00B | inf% |
| 2023-04-30 | $-0.01B | $0.00B | -700.00% |
| 2023-01-31 | $-0.01B | $0.00B | 1400.00% |
| 2022-10-31 | $-0.01B | $0.00B | 1400.00% |
| 2022-07-31 | $-0.01B | $0.00B | 800.00% |
| 2022-04-30 | $-0.01B | $-0.01B | 333.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.006B | $0.000B |
| HeartSciences is an artificial intelligence powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The company's product candidate includes the MyoVista(R) wavECG(TM) or the MyoVista(R). HeartSciences , formerly known as Heart Test Laboratories Inc., is based in Southlake, TX. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $34.790B | 19.11 |
| Inspire Medical Systems (INSP) | United States | $7.322B | 0.00 |
| 10x Genomics (TXG) | United States | $3.489B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
| Axonics (AXNX) | United States | $3.396B | 0.00 |
| Enovis (ENOV) | United States | $3.029B | 23.01 |
| Azenta (AZTA) | United States | $2.925B | 238.46 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
| Privia Health (PRVA) | United States | $2.183B | 96.84 |
| Schrodinger (SDGR) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.231B | 30.12 |
| Phreesia (PHR) | United States | $1.169B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.608B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
| Pulmonx (LUNG) | United States | $0.293B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| Outset Medical (OM) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.116B | 4.94 |
| 111 (YI) | China | $0.087B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |